0001209191-19-024119.txt : 20190409
0001209191-19-024119.hdr.sgml : 20190409
20190409172418
ACCESSION NUMBER: 0001209191-19-024119
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20190408
FILED AS OF DATE: 20190409
DATE AS OF CHANGE: 20190409
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Castellanos Elaine
CENTRAL INDEX KEY: 0001662520
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37785
FILM NUMBER: 19740151
MAIL ADDRESS:
STREET 1: C/O REATA PHARMACEUTICALS, INC.
STREET 2: 2801 GATEWAY DR. SUITE 150
CITY: IRVING
STATE: TX
ZIP: 75063
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: REATA PHARMACEUTICALS INC
CENTRAL INDEX KEY: 0001358762
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 113651945
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 2801 GATEWAY DRIVE SUITE 150
CITY: IRVING
STATE: TX
ZIP: 75063
BUSINESS PHONE: 972-865-2206
MAIL ADDRESS:
STREET 1: 2801 GATEWAY DRIVE SUITE 150
CITY: IRVING
STATE: TX
ZIP: 75063
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2019-04-08
0
0001358762
REATA PHARMACEUTICALS INC
RETA
0001662520
Castellanos Elaine
2801 GATEWAY DRIVE
SUITE 150
IRVING
TX
75063
0
1
0
0
Principal Accounting Officer
Class A common stock
2019-04-08
4
C
0
2000
A
4138
D
Class A common stock
2019-04-08
4
S
0
2000
90.17
D
2138
D
Employee Stock Option (right to buy)
11.00
2019-04-08
4
M
0
2000
0.00
D
2026-05-25
Class B common stock
2000
41434
D
Class B common stock
2019-04-08
4
M
0
2000
11.00
A
Class A common stock
2000
2000
D
Class B common stock
2019-04-08
4
C
0
2000
D
Class A common stock
2000
0
D
The exercise, conversion and sale reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 7, 2019.
The Class B common stock is convertible into Class A common stock on a one-for-one basis at the holder's election at any time. The conversion right of the Class B common stock has no expiration date.
The options vest in sixteen equal quarterly installments beginning on August 25, 2016.
/s/ Michael D. Wortley, attorney-in-fact
2019-04-09